# Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12‐week, placebo‐controlled study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-indacaterol-150-and-300-g-in-chronic-obstructive/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masaharu Kinoshita,Sang Haak Lee,Liang‐Wen Hang,Masakazu Ichinose,Motoi Hosoe,Naoko Okino,Niyati Prasad,Benjamin Krämer,Yoshinosuke Fukuchi,FOR THE INDACATEROL ASIAN COPD STUDY INVESTIGATORS |
| Citations | 41 |
| DOI | 10.1111/j.1440-1843.2011.02107.x |
| Fields | Agricultural and Biological Sciences,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1952594708 |
| PMID | 22122202 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Liang‐Wen Hang](https://scholariq.org/researchers/liang-wen-hang/)

## Paper primary topic

- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)

## Paper topics

- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Pharmacological Effects and Assays](https://scholariq.org/topics/pharmacological-effects-and-assays/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.